Carbon Biosciences
Jianming Qiu has worked in a variety of roles in the scientific field. In 2022, they became Co-Founder & Advisor at Carbon Biosciences. From 2006-2022, they worked at the University of Kansas Medical Center as a Professor, Associate Professor, and Assistant Professor. From 1999-2006, they worked at the University of Missouri-Columbia as a Research Assistant Professor and Postdoc Fellow. From 1996-1999, they were a Visiting Fellow at the National Heart, Lung, and Blood Institute. From 1994-1996, they worked as an Assistant Professor at the Institute of Virology in Beijing.
Jianming Qiu earned a Bachelor's degree in Veterinary Medicine from Zhejiang University in 1985. Jianming then went on to receive a Master of Science (MS) in Biochemistry from Zhejiang University in 1988. Finally, they completed a Ph.D. in Virology from the Institute of Virology in Beijing in 1994.
This person is not in any teams
This person is not in any offices
Carbon Biosciences
1 followers
Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues, carry a larger cargo, with minimal neutralizing immunity and the potential to re-dose. Founded by Longwood Fund and gene therapy pioneers John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D., Carbon is expanding the gene therapy toolbox for the treatment of the world’s most devastating and difficult to treat diseases.